Asit K. Paul

Also affiliated with Virginia Cancer Institute, VCU Massey Comprehensive Cancer Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Randomized phase II study of olaparib with or without cediranib in men with metastatic castration-resistant prostate cancer (mCRPC).”.

Randomized phase II study of olaparib with or without cediranib in men with metastatic castration-resistant prostate cancer (mCRPC).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.111

N/A

0DataRank · unranked

6 citations

Rana R. McKay, Mary‐Ellen Taplin, Nancy B. Davis, Paul Monk, Leonard J. Appleman +14 more

MDA-9/Syntenin in the tumor and microenvironment defines prostate cancer bone metastasis

Proceedings of the National Academy of Sciences(2023)10.1073/pnas.2307094120

N/A

0DataRank · unranked

15 citations

Anjan K. Pradhan, Amit Kumar, Praveen Bhoopathi, Padmanabhan Mannangatti, Chunqing Guo +18 more